ID 500 - Kwas alfa-linolenowy

PL: Kwas alfa-linolenowy
EN: Alpha-linolenic acid (LNA-Omega 3)
Pdf: various food(s)/food constituent(s) that are referring to children’s development

Oświadczenie (2)

1.6. Leczenie chorób (ID 500)

The claimed effect is "a high LNA to LA ratio has positive effects on eicosanoids and thus protects against inflammatory and thrombotic reactions". The Panel assumes that the target population is the general population.
From the clarifications provided by Member States and the references provided, the Panel assumes that the claimed effect refers to the treatment of disease (e.g. rheumatoid arthritis and asthma).
The Panel considers that the claimed effect is related to the treatment of diseases and does not comply with the criteria laid down in Regulation (EC) No 1924/2006.

Warunki i możliwe ograniczenia stosowania oświadczenia

>1.5g per day (BNF CVD 2005 p.217)